3-T magnetic resonance–guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors

Data from a single-center prospective study of 12 patients with symptomatic bone metastases treated with MRI-guided focused ultrasound demonstrated complete and partial responses of current pain in six and six patients, respectively, as well as a complete breakthrough cancer pain response in five patients. Further, no treatment-related adverse events were reported.